WeCanManage. An mHealth Self-management Tool
Phase NA Completed
20 enrolled
NAVIGATE
Phase 2 Completed
215 enrolled 3 FDA
AYAConnect
Phase NA Completed
63 enrolled
PRIORITY
Completed
346 enrolled 9 charts
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Completed
490 enrolled
PREFER
Completed
1,429 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Dendritic Cell Vaccination for Patients with Solid Tumors
Phase 1/2 Completed
48 enrolled
DUET-3
Phase 1 Completed
198 enrolled
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Phase 1 Completed
22 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
203 enrolled
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
A Study of PRT2527 in Participants With Advanced Solid Tumors
Phase 1 Completed
30 enrolled
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Phase NA Completed
41 enrolled
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
Phase 1 Completed
38 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
Mini-allo
Phase NA Completed
36 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase NA Completed
9 enrolled
L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Phase 1 Completed
29 enrolled
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Phase NA Completed
390 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy
Phase NA Completed
90 enrolled
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Phase 1 Completed
26 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Phase NA Completed
1,053 enrolled
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Phase NA Completed
10 enrolled
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Phase 1 Completed
37 enrolled
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Phase 1 Completed
17 enrolled
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
16 enrolled
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Phase 1 Completed
111 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
30 enrolled
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Phase 1/2 Completed
70 enrolled
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase 2 Completed
51 enrolled 6 charts
Spectroscopy With Surface Coils and Decoupling
Phase 1 Completed
582 enrolled
LUM015
Phase 1 Completed
15 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
IFNa
Phase 1 Completed
35 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled